Technetium-99m albumin scintigraphy in the diagnosis of protein-losing enteropathy.

Fecal clearance of alpha1-antitrypsin with lansoprazole can detect protein-losing gastropathy. Dig Dis Sci (1999) 0.89

99mTc-HSA-D scintigraphy in the diagnosis of protein-losing gastroenteropathy due to secondary amyloidosis. J Gastroenterol (1997) 0.88

Protein-losing enteropathy associated with systemic lupus erythematosus: response to cyclophosphamide. Rheumatol Int (2004) 0.87

Outcome of surgical resection for protein-losing enteropathy in systemic lupus erythematosus. Clin Rheumatol (2008) 0.78

Eosinophilic enterocolitis diagnosed by means of technetium-99m albumin scintigraphy and treated with budesonide (CIR). Gut (1994) 0.76

Applicability of (99m) Tc-Labeled Human Serum Albumin Scintigraphy in Dogs With Protein-Losing Enteropathy. J Vet Intern Med (2017) 0.75

A case of primary intestinal lymphangiectasia. Korean J Intern Med (1993) 0.75

Protein-losing enteropathy due to thrombophlebitis of the mesenteric vein: report of a case. Surg Today (1998) 0.75

Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg (1998) 2.32

Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst (1991) 2.19

Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol (1999) 2.02

[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab (1999) 1.90

The case for and technique of heterotopic liver grafting. Transplant Proc (1979) 1.87

Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg (1999) 1.67

111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology (1998) 1.59

Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol (2001) 1.44

Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer. Radiology (1999) 1.42

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. J Clin Oncol (1991) 1.42

Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol (1994) 1.41

Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. J Clin Oncol (1993) 1.35

3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study. Int J Oncol (1998) 1.35

Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33. J Clin Oncol (1990) 1.28

67Ga-citrate imaging in untreated Hodgkin's disease: preliminary report of Cooperative Group. J Nucl Med (1974) 1.28

Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol (1996) 1.21

Predicting tumor response in patients with colorectal hepatic metastases. Ann Surg (1985) 1.20

Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol (1996) 1.18

A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg (2001) 1.17

Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer (1987) 1.16

Clinical liver heterotopic (auxiliary) transplantation. Surgery (1973) 1.11

Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol (1994) 1.06

A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity. Blood (1994) 1.03

Effect of tetracycline on intestinal absorption of various nutrients by the rat. Proc Soc Exp Biol Med (1966) 0.99

Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery (2001) 0.98

Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias. J Clin Oncol (1993) 0.97

Completion of the Genome Sequence of Watermelon silver mottle virus and Utilization of Degenerate Primers for Detecting Tospoviruses in Five Serogroups. Phytopathology (2001) 0.96

Jod-Basedow syndrome following oral iodine and radioiodinated-antibody administration. J Nucl Med (1997) 0.96

Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias. Bone Marrow Transplant (2003) 0.95

Bone sarcomas in Paget disease: a study of 85 patients. Radiology (1984) 0.95

Lymphoscintigraphy and sentinel node localization in breast cancer patients: a comparison between 1-day and 2-day protocols. J Nucl Med (2001) 0.94

Abnormal gallium scintigraphy in Pneumocystis carinii pneumonia with a normal chest radiograph. Radiology (1978) 0.93

Absorption studies in canine jejunal allografts. Ann Surg (1971) 0.91

Novel investigative approaches for advanced renal cell carcinoma. Semin Oncol (2000) 0.90

Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer. J Nucl Med (1994) 0.90

Efficient transformation of papaya by coat protein gene of papaya ringspot virus mediated byAgrobacterium following liquid-phase wounding of embryogenic tissues with caborundum. Plant Cell Rep (1996) 0.89

Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma. Eur J Nucl Med (1993) 0.89

Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry. J Nucl Med (2000) 0.89

Serological and Molecular Characterization of Peanut chlorotic fan-spot virus, a New Species of the Genus Tospovirus. Phytopathology (2001) 0.88

Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice. Int J Oncol (1998) 0.88

The value of diagnostic aids in detecting pancreas cancer. Cancer (1978) 0.88

Quantitive aspects of cycloheximide inhibition of amino acid incorporation. Biochem Pharmacol (1969) 0.88

Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. J Am Coll Surg (1999) 0.88

Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial. Eur J Nucl Med (1996) 0.87

Brain scanning in children. JAMA (1967) 0.87

Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemia. Cancer (1994) 0.86

Scintigraphic features of primary sacral tumors. J Nucl Med (1986) 0.86

Diagnostic nuclear medicine, today and tomorrow. Med Clin North Am (1971) 0.85

Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med (1982) 0.85

Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients. Br J Clin Pharmacol (2001) 0.85

Heterotopic (auxiliary) liver transplantation in man. Transplant Proc (1977) 0.84

The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med (1994) 0.84

Tumors of the liver as demonstrated by angiography, scan and laparotomy. Surg Gynecol Obstet (1975) 0.83

Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum. J Nucl Med (1992) 0.82

Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med (1995) 0.82

Lymphoscintigraphy in the staging of solid tumors. Surg Gynecol Obstet (1983) 0.81

Tetracycline and incorporation of amino acids into proteins of rat tissues. Proc Soc Exp Biol Med (1966) 0.81

A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression. J Clin Oncol (1990) 0.81

Quantitative scanning of osteogenic sarcoma with nitrogen-13-labeled L-glutamate. J Nucl Med (1979) 0.81

Comparative reactions of recombinant papaya ringspot viruses with chimeric coat protein (CP) genes and wild-type viruses on CP-transgenic papaya. J Gen Virol (2001) 0.80

Single chain antigen binding protein (sFv CC49): first human studies in colorectal carcinoma metastatic to liver. Cancer (1997) 0.80

Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer. Clin Cancer Res (1998) 0.80

Cycloheximide inhibition of gastric secretion in the rat. Proc Soc Exp Biol Med (1969) 0.80

Long-term follow-up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin. Cancer Treat Rep (1986) 0.80

Clinical applications of fusion imaging in oncology. Nucl Med Biol (1994) 0.79

Hiatal hernia on whole-body radioiodine survey mimicking metastatic thyroid cancer. Clin Nucl Med (1993) 0.79

Image registration of SPECT and CT images using an external fiduciary band and three-dimensional surface fitting in metastatic thyroid cancer. J Nucl Med (1995) 0.79

Intratumoral consumption of indium-111 labeled platelets in a patient with hemangiomatosis and intravascular coagulation (Kasabach-Merritt syndrome). Cancer (1983) 0.79

131I-3F8: clinical validation of imaging studies and therapeutic applications. Prog Clin Biol Res (1991) 0.79

New concepts in structure and function of dog jejunal allografts. Surg Forum (1970) 0.79

Modeling and dosimetry of monoclonal antibody M195 (anti-CD33) in acute myelogenous leukemia. J Nucl Med (1993) 0.78

Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma. Cancer (1997) 0.78

Clinical validation of SPECT and CT/MRI image registration in radiolabeled monoclonal antibody studies of colorectal carcinoma. J Nucl Med (1994) 0.78

Carotid body paraganglioma metastatic to bone: report of two cases. Skeletal Radiol (1998) 0.78

Divergence and conservation of the genomic RNAs of Taiwan and Hawaii strains of papaya ringspot potyvirus. Arch Virol (1997) 0.78

Comparison of ambisense m RNA of watermelon silver mottle virus with other tospoviruses. Phytopathology (1998) 0.78

Protective effect of ascorbic acid, isoascorbic acid and mannitol against tetracycline-induced nephrotoxicity. J Pharmacol Exp Ther (1971) 0.78

Imaging of brain tumors after administration of L-(N-13)glutamate: concise communication. J Nucl Med (1982) 0.78

Progress in radioactive isotope scanning. Med Clin North Am (1966) 0.78

Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma. J Clin Oncol (1993) 0.77

Overview of clinical radioimmunodetection of human tumors. Cancer (1994) 0.77

Scanning with L-(13 N) glutamate: Assessment of the response to chemotherapy of a patient with embryonal rhabdomyosarcoma. Am J Clin Oncol (1982) 0.76

Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer. Clin Cancer Res (1999) 0.76

Gallium-67-citrate imaging in nuclear oncology. Nucl Med Biol (1994) 0.76

Quotient imaging with N-13 L-glutamate in osteogenic sarcoma: correlation with tumor viability. Cancer (1981) 0.76

The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors. Clin Nucl Med (1992) 0.76

Behavioral thermoregulation during vitamin B6 deficiency. Am J Physiol (1963) 0.76

Anticancer Chinese herbal medicines. Am J Chin Med (Gard City N Y) (1973) 0.76

Imaging of the human heart after administration of L-(N-13)glutamate. J Nucl Med (1980) 0.76

Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma. Clin Cancer Res (2001) 0.75

Heteroduplex Mobility and Sequence Analyses for Assessment of Variability of Zucchini yellow mosaic virus. Phytopathology (2000) 0.75

Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors. Eur J Nucl Med (1995) 0.75

Imaging of primary Ewing sarcoma with 13N-L-glutamate. Radiology (1982) 0.75

Gallium uptake in heterotransplanted human choriocarcinoma and ovarian carcinoma in nude mice. Proc Soc Exp Biol Med (1980) 0.75